microdosing tirzepatide schedule chart: Guide to benefits, dosage and safety Microdosing Tirzepatide + Glycine Product

If accuracy at low doses is a concern, some prescribers deliberately start patients on the 8mg/mL vial for the first four to eight weeks, then switch to 17mg/mL for higher doses

Commonly reported side effects in this class include nausea, vomiting, diarrhea, constipation, and injection-site reactions

Thats why they may help with addictions and other habits, too

A dose from an expired vial may deliver significantly less active medication than intended, leaving you with an underdose effect

This is slightly higher than tirzepatide (+23 bpm) or semaglutide (+34 bpm), though no increase in serious cardiovascular events was observed in Phase 2